Ionis Pharmaceuticals
IONS
IONS
360 hedge funds and large institutions have $5.6B invested in Ionis Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 106 increasing their positions, 137 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
360
Holders Change
-29
Holders Change %
-7.46%
% of All Funds
7.95%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
35
Increased
106
Reduced
137
Closed
61
Calls
$30.9M
Puts
$46.5M
Net Calls
-$15.6M
Net Calls Change
-$1.77M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$89.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$60.1M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$15.1M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$10.4M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$9.86M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$130M |
| 2 |
D.E. Shaw & Co
New York
|
-$24.8M |
| 3 |
Renaissance Technologies
New York
|
-$16.6M |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$16.5M |
| 5 |
SI
Scout Investments
Kansas City,
Missouri
|
-$15.6M |